{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:34:42Z","timestamp":1793712882800,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.annepidem.2026.110276","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:03:25Z","timestamp":1788793405000},"page":"110276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Age-specific HPV prevalence and genotype distribution in a highly vaccinated population"],"prefix":"10.1016","volume":"123","author":[{"given":"Antonio","family":"Urbano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"S\u00e1nchez-Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"V\u00e1zquez-Conejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Castej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Ochando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2026.110276_bib1","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.annepidem.2026.110276_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2026.110276_bib3","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017\u2013Recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.annepidem.2026.110276_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110276_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2026.110276_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2377903","article-title":"Long-term effectiveness of the nine-valent human papillomavirus vaccine: interim results after 12 years of follow-up in Scandinavian women","volume":"20","author":"Kjaer","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.annepidem.2026.110276_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.633162","article-title":"Genotype distribution change after human papillomavirus vaccination in two autonomous communities in Spain","volume":"11","author":"Freire-Salinas","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.annepidem.2026.110276_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2026.110276_bib9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.annepidem.2026.110276_bib10","unstructured":"Conselleria de Sanidad Universal y Salud P\u00fablica GV. Sanidad administra cerca de 86.000 dosis de la vacuna frente al virus del papiloma humano a menores a partir de 12 a\u00f1os 2024."},{"key":"10.1016\/j.annepidem.2026.110276_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2021.11.062","article-title":"Human papillomavirus vaccines effectiveness to prevent genital warts: a population-based study using health system integrated databases, 2009\u20132017","volume":"40","author":"Mu\u00f1oz-Quiles","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.annepidem.2026.110276_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102372","article-title":"A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine","volume":"84","author":"Ruan","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.annepidem.2026.110276_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jasc.2025.03.006","article-title":"Human papillomavirus genotype distribution and its correlation with intraepithelial neoplasia, vaccination, and ethnicity","volume":"14","author":"Abi-Raad","year":"2025","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.annepidem.2026.110276_bib14","doi-asserted-by":"crossref","first-page":"F117","DOI":"10.1016\/j.vaccine.2012.05.071","article-title":"Introduction of human papillomavirus DNA screening in the world: 15 years of experience","volume":"30","author":"Castle","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.annepidem.2026.110276_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annepidem.2026.110276_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiz555","article-title":"Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses","volume":"221","author":"Markowitz","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110276_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.annepidem.2026.110276_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiq139","article-title":"Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical Disease","volume":"203","author":"Chaturvedi","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110276_bib19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.7326\/M21-3798","article-title":"Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003\u20132018","volume":"175","author":"Rosenblum","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annepidem.2026.110276_bib20","first-page":"586","article-title":"Ten-year evaluation of HPV vaccine influence on non-vaccine-type-related cervical infections and precancers in Chinese females: follow-up from a randomized control trial","volume":"5","author":"Wen","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.annepidem.2026.110276_bib21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.vaccine.2005.09.054","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.annepidem.2026.110276_bib22","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1158\/1055-9965.EPI-05-0465","article-title":"Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections","volume":"14","author":"Chaturvedi","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.annepidem.2026.110276_bib23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726002747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726002747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:01:08Z","timestamp":1793710868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279726002747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"alternative-id":["S1047279726002747"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110276","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-specific HPV prevalence and genotype distribution in a highly vaccinated population","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110276"}}